Loss of heterozygosity of chromosome 10q has been reported in hepatoma. Are
as,with a high rate of loss of genetic material could harbor putative turne
r suppressor genes. PTEN/MMAC1, a candidate tumor suppressor gene located a
t chromosome 10q23.3, has recently been identified and found to be homozygo
usly deleted or mutated in several different types of human tumors. To dete
rmine whether the PTEN/ MMAC1 gene is a target of 10q loss of heterozygosit
y in hepatoma, we examined 42 primary hepatomas for mutations in PTEN/MMAC1
by using nested reverse transcriptase polymerase chain reaction (RT-PCR) o
f the RNA and single-stranded conformation polymorphism (SSCP) analysis of
all genomic exons. Although 2 of 42 hepatoma tissues had aberrant transcrip
ts, 5 matched noncancerous liver tissues also had aberrant transcripts. Sou
thern blot analysis of the entire genomic DNA revealed no genomic change. T
herefore, like the TSG101 or FHIT gene, aberrant transcripts of PTEN/MMAC1
using the nested RT-PCR method were a common phenomenon for both cancerous
and noncancerous liver tissues, which may nor be related to oncogenesis. No
ne of the 42 cases had small deletions, point mutations, or insertions. Our
results suggest that the PTEN/MMAC1 gene may not play a role in the pathog
enesis of hepatoma.